SCIENTURE HOLDINGS, INC. Deferred Tax Liabilities, Net
SCIENTURE HOLDINGS, INC. (SCNX) had Deferred Tax Liabilities, Net of $16.05 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilities · last filed 2026-03-30
- 2025-12-31: Deferred Tax Liabilities, Net $16.05M.
- 2024-12-31: Deferred Tax Liabilities, Net $13.53M; Deferred Tax Liabilities, Net as first filed $16.05M.
- 2023-12-31: Deferred Tax Liabilities, Net $143.43K.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2025-12-31 | $16.05M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $13.53M 10-K · filed 2026-03-30 | $16.05M 10-K · filed 2025-03-26 |
| 2023-12-31 | $143.43K 10-K · filed 2025-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |